To estimate the effect of hemolysis, we prepared four serum poolswith different amounts of bilirubin. Hemoglobin prepared from lysed erythrocytes was added to each pool to give Hb concentrations of 0.5, 1.5, and 2.5 g/L in pooled serum. Results were as follows: 
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We conclude that results by the Dri-STAT method for total bilirubin determination in the RA-b000 compare well with those by the Jendrassik-GrOf procedure in the SMAC II. We use the Dri-STAT reagent for samples from patients requiring only a value for total biirubin rather than the entire set of determinations provided by SMAC II, and in cases where the quantity of the sample is extremely small.
For early detection of hypermyoglobinemia
we use a latex-agglutination test (RapiTex#{174}; Behringwerke AG, Marburg, F.R.G.) that originally was designed for early exclusion of acute myocardial infarction (AM1), with a lower detection limit of 100 .ig/L (1). Higher concentrations of myoglobin in serum can be estimated semiquantitatively by the latex-agglutination test, either from serial dilutions or from the interval until agglutination becomes visible (2) .
Recently we investigated serum myoglobin by the latexagglutination test in a patient with acute bilateral arterial occlusion in the lower extremities and suspected AMI.
Agglutination occurred in a 10-fold diluted sample but not in the undiluted sample. Subsequent 100-fold dilution also produced agglutination, indicating a myoglobin concentration exceeding 10 000 zg/L. In blood sampled the next day we found no agglutination in undiluted or 100-fold diluted serum, whereas agglutination was found in both 10-fold and 50-fold diluted serum, indicating a myoglobin concentration between 5000 and 10 000 .tg/L.
The reagent of the latex-agglutination test consists of a suspension of latex particles coated with antibodies to human myoglobin. If the serum myoglobin is less than 100 .tg/L, excess antibody prevents immunological crosslunking and visible agglutination ("prozone phenomenon"), whereas agglutination is readily seen in the zone of equivalence. However, if excessantigen is present, the test yields a falsenegative result ("postzonephenomenon") (3). In our patient, RA The "Sera-Pak" immuno kit (Miles Laboratories Limited, Stoke Poges, Slough, SL2 4LY, U.K.) for estimating albumin in urine is based on the formation of immunocomplexes (1), in the presence of polyethylene glycol, resulting from the reaction between albumin in the sample and a specific antibody. The turbidity formed, which is proportional to the concentration of albumin, is measured as an increase in absorbance at 340 nm and compared against a series of calibrators to give the albumin concentration.
For use in the RA-1000, the reagents were used according to the manufacturer's instructions. A calibration curve, which should be assayed for each new batch of reagents, was found to be stable for at least six weeks. The range of the assay was up to 160 mgfL, with antigen excess evident at 1 g/L. Consequently, all specimens must be screened for possible antigen excess by using Albustix (Miles) and, if greater than + positive, analyzed afterdilution. The CV for
